
Relay Therapeutics Investor Relations Material
Latest events

Study Update
Relay Therapeutics

Q1 2025
5 May, 2025

Q4 2024
26 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Relay Therapeutics Inc
Access all reports
Relay Therapeutics Inc. is a clinical-stage precision medicine company focusing on the development of small molecule therapeutics. The company operates at the intersection of computational and experimental technologies to enhance drug discovery, particularly in the areas of targeted oncology and genetic diseases. Relay Therapeutics utilizes its proprietary Dynamo platform to address previously intractable or inadequately drugged protein targets by leveraging insights into protein motion and function. This platform integrates various cutting-edge computational and experimental methods to facilitate the drug discovery process. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Relay Therapeutics Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
Relay Therapeutics Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
Relay Therapeutics Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
RLAY
Country
🇺🇸 United States